HealthCareMagic is now Ask A Doctor - 24x7 | https://www.askadoctor24x7.com

Get your health question answered instantly from our pool of 18000+ doctors from over 80 specialties
159 Doctors Online

By proceeding, I accept the Terms and Conditions

Dr. Andrew Rynne
MD
Dr. Andrew Rynne

Family Physician

Exp 50 years

HCM Blog Instant Access to Doctors
HCM BlogQuestions Answered
HCM Blog Satisfaction

Aural Fullness And/or Autophony (DiBartolomeo's Syndrome) PatulEnd® Is Only Orphan

Aural fullness and/or autophony (DiBartolomeo's Syndrome) PatulEnd® is only Orphan product that is NORD approved, now drug-free, with Exclusivity for treating the Patulous Eustachian Tube disorder. . Can it be included in the Eustachian tube or middle ear disorders. Thank you.
In accordance with Orphan Drug Application of April 23, 1996 submitted pursuant to Section 526 of the Federal Food Drug and Cosmetic Act for the designation of PatulEND® Orphan Drug for the treatment of the rare, Orphan, Patulous Eustachian tube anomaly disorder.

Approval was determined by the Office of Orphan Products Development (HF35) Food and Drug Administration, February 18, 1997, by Marlene E. Haffner, MD. M.P.H.
Rear Admiral United States Public Service, Director, Office of Orphan Product Development
Dr. Rynne, Thank you for " making a difference. Joseph Di Bartolomeo, MDF, FACS, UCLA, H & N.
Fri, 15 Jan 2016
Report Abuse
For a more detailed, immediate answer, try our premium service [Sample answer]
Share on
 

Related questions you may be interested in


Loading Online Doctors....
Aural Fullness And/or Autophony (DiBartolomeo's Syndrome) PatulEnd® Is Only Orphan